1832 Asset Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $311M | Buy |
1,053,209
+420,634
| +66% | +$125M | 0.29% | 72 |
|
|
2025
Q4 | $173M | Buy |
632,575
+173,252
| +38% | +$47.1M | 0.13% | 110 |
|
|
2025
Q3 | $124M | Sell |
459,323
-4,648
| -1% | -$1.26M | 0.1% | 113 |
|
|
2025
Q2 | $128M | Sell |
463,971
-695,627
| -60% | -$189M | 0.1% | 116 |
|
|
2025
Q1 | $308M | Buy |
1,159,598
+393,755
| +51% | +$97.1M | 0.28% | 46 |
|
|
2024
Q4 | $178M | Sell |
765,843
-54,259
| -7% | -$12.5M | 0.15% | 84 |
|
|
2024
Q3 | $181M | Sell |
820,102
-26,205
| -3% | -$5.42M | 0.14% | 85 |
|
|
2024
Q2 | $166M | Sell |
846,307
-62,608
| -7% | -$12.9M | 0.14% | 87 |
|
|
2024
Q1 | $196M | Buy |
908,915
+138,715
| +18% | +$29.1M | 0.12% | 76 |
|
|
2023
Q4 | $162M | Buy |
770,200
+136,645
| +22% | +$29.2M | 0.23% | 83 |
|
|
2023
Q3 | $127M | Sell |
633,555
-104,987
| -14% | -$20.9M | 0.18% | 91 |
|
|
2023
Q2 | $137M | Buy |
738,542
+114,543
| +18% | +$21.2M | 0.16% | 85 |
|
|
2023
Q1 | $120M | Buy |
623,999
+566,899
| +993% | +$103M | 0.17% | 88 |
|
|
2022
Q4 | $9.6M | Buy |
57,100
+24,519
| +75% | +$4.26M | 0.02% | 350 |
|
|
2022
Q3 | $5.77M | Buy |
32,581
+181
| +0.6% | +$35.8K | 0.01% | 416 |
|
|
2022
Q2 | $6.63M | Buy |
32,400
+4,500
| +16% | +$954K | 0.01% | 406 |
|
|
2022
Q1 | $6.54M | Hold |
27,900
| – | – | 0.01% | 428 |
|
|
2021
Q4 | $6.45M | Sell |
27,900
-2,516
| -8% | -$554K | 0.01% | 352 |
|
|
2021
Q3 | $6M | Sell |
30,416
-124,841
| -80% | -$25.3M | 0.01% | 387 |
|
|
2021
Q2 | $33.1M | Sell |
155,257
-967,953
| -86% | -$204M | 0.06% | 208 |
|
|
2021
Q1 | $231M | Sell |
1,123,210
-186,583
| -14% | -$36.8M | 0.5% | 61 |
|
|
2020
Q4 | $234M | Buy |
1,309,793
+889,890
| +212% | +$151M | 0.55% | 52 |
|
|
2020
Q3 | $70.1M | Buy |
419,903
+78,014
| +23% | +$13.1M | 0.18% | 118 |
|
|
2020
Q2 | $55.8M | Buy |
341,889
+315,176
| +1,180% | +$56.5M | 0.17% | 128 |
|
|
2020
Q1 | $4.68M | Buy |
+26,713
| New | +$5.32M | 0.02% | 303 |
|
|
2019
Q3 | – | Sell |
-64
| Closed | -$12K | – | 679 |
|
|
2019
Q2 | $12K | Buy |
64
+4
| +7% | +$737 | ﹤0.01% | 632 |
|
|
2019
Q1 | $10K | Hold |
60
| – | – | ﹤0.01% | 569 |
|
|
2018
Q4 | $11K | Hold |
60
| – | – | ﹤0.01% | 555 |
|
|
2018
Q3 | $10K | Sell |
60
-60
| -50% | -$10.1K | ﹤0.01% | 593 |
|
|
2018
Q2 | $20K | Sell |
120
-215
| -64% | -$35.1K | ﹤0.01% | 547 |
|
|
2018
Q1 | $54K | Hold |
335
| – | – | ﹤0.01% | 523 |
|
|
2017
Q4 | $49K | Sell |
335
-2,002
| -86% | -$285K | ﹤0.01% | 543 |
|
|
2017
Q3 | $309K | Buy |
+2,337
| New | +$295K | ﹤0.01% | 490 |
|
|
2013
Q3 | – | Sell |
-110,300
| Closed | -$8.38M | – | 385 |
|
|
2013
Q2 | $8.38M | Buy |
+110,300
| New | +$7.24M | 0.04% | 252 |
|
Other funds holding CME
VCM
VPM
1832 Asset Management's CME Position: Q1 2026 in Review
1832 Asset Management increased its CME Group (CME) stake by 66% in Q1 2026, buying an estimated $125M and bringing the position to 1,053,209 shares worth $311M. The position accounts for 0.29% of the portfolio, ranked #72.
1832 Asset Management first reported a position in CME in Q2 2013 and has held it in 34 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- 1832 Asset Management held 1,053,209 shares of CME Group worth $311M as of Q1 2026.
- 1832 Asset Management bought 420,634 CME Group shares in Q1 2026, an estimated $125M.
- CME Group made up 0.29% of 1832 Asset Management's portfolio in Q1 2026, its #72 holding.
- 1832 Asset Management first reported a position in CME Group in Q2 2013 and has held it in 34 quarters since.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on 1832 Asset Management's 13F filing for Q1 2026, filed 14 May 2026.